Literature DB >> 23978509

Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays.

Gus Koerbin1, Walter P Abhayaratna, Julia M Potter, Fred S Apple, Allan S Jaffe, Tricia H Ravalico, Peter E Hickman.   

Abstract

OBJECTIVE: Using objective laboratory and clinical criteria to more accurately determine the 99th percentile values for cardiac troponin I and T. DESIGN AND METHODS: We measured cardiac troponin T and cardiac troponin I with high-sensitivity assays in a large cohort of apparently healthy community subjects and calculated 99th percentiles for different sexes and ages. Subjects with possible subclinical disease were eliminated based on objective laboratory criteria, eGFR and NT-proBNP, and clinical criteria, history and examination and echocardiogram.
RESULTS: For men and women of all ages, separately, more than 50% of subjects were excluded using these criteria, with a lesser proportion of younger subjects being excluded. In men aged <75 years, the 99th percentile for cTnI decreased by more than 50% from 22.9 ng/L to 10.3 ng/L. In other age groups and for cTnT the decrease was smaller (%) but still considerable.
CONCLUSIONS: For establishing cardiac troponin 99th percentiles, simply using self-reporting of health is insufficient. Objective laboratory measures and clinical and echocardiographic assessments are essential to define a healthy population, especially in older persons.
© 2013. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists. All rights reserved.

Entities:  

Keywords:  99th percentile; Reference population; Troponin I; Troponin T

Mesh:

Substances:

Year:  2013        PMID: 23978509     DOI: 10.1016/j.clinbiochem.2013.08.004

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  15 in total

1.  Influence of exercise intensity and duration on functional and biochemical perturbations in the human heart.

Authors:  Glenn M Stewart; Akira Yamada; Luke J Haseler; Justin J Kavanagh; Jonathan Chan; Gus Koerbin; Cameron Wood; Surendran Sabapathy
Journal:  J Physiol       Date:  2016-02-18       Impact factor: 5.182

Review 2.  Revisiting the Biological Variability of Cardiac Troponin: Implications for Clinical Practice.

Authors:  Nick S R Lan; Damon A Bell
Journal:  Clin Biochem Rev       Date:  2019-11

3.  Influence of Age on the Diagnosis of Myocardial Infarction.

Authors:  Matthew T H Lowry; Dimitrios Doudesis; Ryan Wereski; Dorien M Kimenai; Christopher Tuck; Amy V Ferry; Anda Bularga; Caelan Taggart; Kuan K Lee; Andrew R Chapman; Anoop S V Shah; David E Newby; Nicholas L Mills; Atul Anand
Journal:  Circulation       Date:  2022-09-15       Impact factor: 39.918

4.  Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin.

Authors:  Karin Wildi; Maria Rubini Gimenez; Raphael Twerenbold; Tobias Reichlin; Cedric Jaeger; Amely Heinzelmann; Christiane Arnold; Berit Nelles; Sophie Druey; Philip Haaf; Petra Hillinger; Nicolas Schaerli; Philipp Kreutzinger; Yunus Tanglay; Thomas Herrmann; Zoraida Moreno Weidmann; Lian Krivoshei; Michael Freese; Claudia Stelzig; Christian Puelacher; Katharina Rentsch; Stefan Osswald; Christian Mueller
Journal:  Circulation       Date:  2015-05-06       Impact factor: 29.690

5.  Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy.

Authors:  Tanja Skyttä; Suvi Tuohinen; Eeva Boman; Vesa Virtanen; Pekka Raatikainen; Pirkko-Liisa Kellokumpu-Lehtinen
Journal:  Radiat Oncol       Date:  2015-07-10       Impact factor: 3.481

6.  Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study.

Authors:  Rodrigo Fernández-Jiménez; Jacobo Silva; Sara Martínez-Martínez; M Dolores López-Maderuelo; Mario Nuno-Ayala; José Manuel García-Ruiz; Ana García-Álvarez; Leticia Fernández-Friera; Tech Gonzalo Pizarro; Jaime García-Prieto; David Sanz-Rosa; Gonzalo López-Martin; Antonio Fernández-Ortiz; Carlos Macaya; Valentin Fuster; Juan Miguel Redondo; Borja Ibanez
Journal:  J Am Heart Assoc       Date:  2015-01-21       Impact factor: 5.501

Review 7.  High-sensitivity troponin assays: evidence, indications, and reasonable use.

Authors:  Matthew W Sherwood; L Kristin Newby
Journal:  J Am Heart Assoc       Date:  2014-01-27       Impact factor: 5.501

8.  High-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients.

Authors:  João Pedro Ferreira; Mário Santos; Sofia Almeida; Irene Marques; Paulo Bettencourt; Henrique Carvalho
Journal:  Cardiol Res Pract       Date:  2014-08-28       Impact factor: 1.866

9.  Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers.

Authors:  Paul Collinson
Journal:  EJIFCC       Date:  2015-08-24

10.  High-Sensitivitycardiac Troponinsin Cardio-Healthy Subjects: A Cardiovascular Magnetic Resonance Imaging Study.

Authors:  Tar-Choon Aw; Wei-Ting Huang; Thu-Thao Le; Chee-Jian Pua; Briana Ang; Soon-Kieng Phua; Khung-Keong Yeo; Stuart A Cook; Calvin W L Chin
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.